---
layout: archive
title: "Publications"
permalink: /publications/
author_profile: true
---

Publications are listed in a chronological order from the oldest to the most recent.

✱ - equal contribution; ✉ - corresponding author; 🅡 – review article; 🅝 – news & views article; 🅟 – pre-print 

1.	*Suskiewicz, M. J.*, Sussman, J. L.✉, Silman, I. & Shaul, Y.✉ Context-dependent resistance to proteolysis of intrinsically disordered proteins. *Protein Sci.* 20, 1285–1297 (2011). 🅡
2.	*Suskiewicz, M. J.* & Clausen, T.✉ Chemical biology interrogates protein arginine phosphorylation. *Cell Chem. Biol.* 23, 888–890 (2016). 🅝
3.	Trentini, D. B.✱, *Suskiewicz, M. J.✱*, Heuck, A., Kurzbauer, R., Deszcz, L., Mechtler, K. & Clausen, T. ✉ Arginine phosphorylation marks proteins for degradation by a Clp protease. *Nature* 539, 48–53 (2016).
4.	Heuck, A.✱, Schitter-Sollner, S.✱, *Suskiewicz, M. J.✱*, Kurzbauer, R., Kley, J., Schleiffer, A., Rombaut, P., Herzog, F. & Clausen, T. ✉ Structural basis for the disaggregase activity and regulation of Hsp104. *Elife* 5, e21516 (2016).
5.	*Suskiewicz, M. J.*, Hajdusits, B., Beveridge, R., Heuck, A., Vu, L. D., Kurzbauer, R., Hauer, K., Thoeny, V., Rumpel, K., Mechtler, K., Meinhart, A., Clausen, T.✉ Structure of McsB, a protein kinase for regulated arginine phosphorylation. *Nat. Chem. Biol.* 15, 510–518 (2019).
6.	*Suskiewicz, M. J.*, Zobel, F., Ogden, T. E. H., Fontana, P., Ariza, A., Yang, J.-C., Zhu, K., Bracken, L., Hawthorne, W. J., Ahel, D., Neuhaus, D. & Ahel, I.✉ HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation. *Nature* 579, 598–602 (2020).
7.	Bilokapic, S., *Suskiewicz, M. J.*, Ahel, I. & Halic, M.✉ Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin. *Nature* 585, 609–613 (2020).
8.	*Suskiewicz, M. J.*, Palazzo, L., Hughes, R. & Ahel, I.✉ Progress and outlook in studying the substrate specificities of PARPs and related enzymes. *FEBS J.* 288, 2131–2142 (2021). 🅡
9.	Asanović, I., Strandback, E., Kroupova, A., Pasajlic, D., Meinhart, A., Tsung-Pin, P., Djokovic, N., Anrather, D., Schuetz, T., *Suskiewicz, M. J.*, Sillamaa, S., Köcher, T., Beveridge, R., Nikolic, K., Schleiffer, A., Jinek, M., Hartl, M., Clausen, T., Penninger, J., Macheroux, P., Weitzer, S., Martinez, J.✉ The oxidoreductase PYROXD1 uses NAD (P)+ as an antioxidant to sustain tRNA ligase activity in pre-tRNA splicing and unfolded protein response. *Mol. Cell* 81, 2520–2532 (2021).
10.	Prokhorova, E.✱, Agnew, T.✱, Wondisford, A. R., Tellier, M., Kaminski, N., Beijer, D., Holder, J., Groslambert, J., *Suskiewicz, M. J.*, Zhu, K., Reber, J. M., Krassnig, S. C., Palazzo, L., Murphy, S., Nielsen, M. L., Mangerich, A., Ahel, D., Baets, J., O’Sullivan, R. J. & Ahel, I.✉ Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease. *Mol. Cell* 81, 2640-2655.e8 (2021).
11.	Prokhorova, E.✱, Zobel, F.*, Smith, R., Zentout, S., Gibbs-Seymour, I., Schützenhofer, K., Peters, A., Groslambert, J., Zorzini, V., Agnew, T., Brognard, J., Nielsen, M. L., Ahel, D., Huet, S., *Suskiewicz, M. J.✉* & Ahel, I.✉ Serine-linked PARP1 auto-modification controls PARP inhibitor response. *Nat. Commun.* 12, 4055 (2021).
12.	Hajdusits, B.✱, *Suskiewicz, M. J.✱*, Hundt, N.✱, Meinhart, A., Kurzbauer, R., Leodolter, J., Kukura, P.✉ & Clausen, T.✉ McsB forms a gated kinase chamber to mark aberrant bacterial proteins for degradation. *Elife* 10, e63505 (2021).
13.	Palazzo, L., *Suskiewicz, M. J.* & Ahel, I.✉ Serine ADP-ribosylation in DNA-damage response regulation. *Curr. Opin. Genet. Dev.* 71, 106–113 (2021). 🅡
14.	Bergoug, M., Mosrin, C., Godin, F., Doudeau, M., Sosic, I., *Suskiewicz, M.*, Vallée, B. & Bénédetti, H.✉ Noncanonical structural requirements of neurofibromin SUMOylation reveal a folding-deficiency of several pathogenic mutants. *bioRxiv* 2021–12 (2021). 🅟
15.	Zhu, K., *Suskiewicz, M. J.✉*, Hloušek-Kasun, A., Meudal, H., Mikoč, A., Aucagne, V.✉, Ahel, D.✉ & Ahel, I. DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on protein substrates. *Sci. Adv.* 8, eadd4253 (2022).
16.	Hunia, J., Gawalski, K., Szredzka, A., *Suskiewicz, M. J.* & Nowis, D.✉ The potential of PARP inhibitors in targeted cancer therapy and immunotherapy. *Front. Mol. Biosci.* 9, 1073797 (2022). 🅡
17.	Fontana, P., Buch-Larsen, S. C., Suyari, O., Smith, R., *Suskiewicz, M. J.*, Schützenhofer, K., Ariza, A.✉, Rack, J. G. M.✉, Nielsen, M. L.✉& Ahel, I.✉ Serine ADP-ribosylation in Drosophila provides insights into the evolution of reversible ADP-ribosylation signalling. *Nat. Commun.* 14, 3200 (2023).
18.	Goffinont, S., Coste, F., Prieu-Serandon, P., Mance, L., Gaudon, V., Garnier, N., Castaing, B. & *Suskiewicz, M. J.✉* Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic. *J. Biol. Chem.* 299, (2023).
19.	*Suskiewicz, M. J.✉✱*, Munnur, D.✱, Strømland, Ø.✱, Yang, J.-C., Easton, L. E., Chatrin, C., Zhu, K., Baretić, D., Goffinont, S., Schuller, M., Wu, W.-F., Elkins, J. M., Ahel, D., Sanyal, S., Neuhaus, D. & Ahel, I.✉ Updated protein domain annotation of the PARP protein family sheds new light on biological function. *Nucleic Acids Res.* gkad514. doi:10.1093/nar/gkad514 (2023)
20.	 *Suskiewicz, M. J.*, Prokhorova, E., Rack, J.G.M., Ahel, I.✉ ADP-ribosylation from molecular mechanisms to therapeutic implications. *Cell*. Oct 12;186(21):4475-95. (2023) 🅡
21.	 Kang, Z.✉, *Suskiewicz, M.J.*, Chatrin, C., Strømland, Ø., Dorsey, B. W., Aucagne, V., Ahel, D.✉, Ahel, I.✉ DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids. *Nucleic Acids Research*. 24 November, gkad1119, https://doi.org/10.1093/nar/gkad1119 (2023)

The most recent publications might be missing - please visit <a href="https://scholar.google.ca/citations?user=Xsix4w8AAAAJ&hl=en">my Google Scholar profile</a>.


  
